Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma – Data From a Dose-Escalation Phase I/II Study - Plesner, T; Lokhorst, H; Gimsing, P (ASH Annual Meeting Abstracts, 2012)
et al.